Pfizer Inc (PFE) financials
Pfizer revenue and earnings by year
Pfizer's revenue was $62.6 billion in the fiscal year to December 31, 2025, down 1.6% from the year before. Net income was $7.77 billion, 12.4% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 1.9% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 62.6 | 63.6 | 59.6 | 101.2 | 81.3 | 41.7 | 40.9 | 40.8 | 52.5 | 52.8 |
| Revenue growth | -1.6% | 6.8% | -41.1% | 24.5% | 95.2% | 1.8% | 0.2% | -22.3% | -0.5% | — |
| Gross profit | 46.5 | 45.8 | 34.6 | 66.8 | 50.5 | 33.2 | 32.9 | 31.8 | 41.3 | 40.5 |
| Gross margin | 74.3% | 71.9% | 58.1% | 66.1% | 62.1% | 79.6% | 80.3% | 78.0% | 78.6% | 76.7% |
| Operating income | 7.5 | 8.0 | 1.1 | 34.7 | 24.3 | 7.0 | 3.2 | 3.6 | 12.3 | 8.4 |
| Operating margin | 12.0% | 12.6% | 1.8% | 34.3% | 29.9% | 16.9% | 7.9% | 8.8% | 23.4% | 15.8% |
| Net income | 7.8 | 8.0 | 2.1 | 31.4 | 22.0 | 9.2 | 16.0 | 11.2 | 21.3 | 7.2 |
| Net margin | 12.4% | 12.6% | 3.6% | 31.0% | 27.0% | 22.0% | 39.2% | 27.3% | 40.6% | 13.7% |
| Diluted EPS | $1.36 | $1.41 | $0.37 | $5.47 | $3.85 | $1.63 | $2.68 | $1.77 | $3.34 | $1.11 |
| Free cash flow | 9.1 | 9.8 | 4.8 | 26.0 | 29.9 | 12.2 | 10.5 | 13.7 | 14.6 | 14.2 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open PFE in Markets.
See also: PFE valuation and P/E history · PFE returns
No forecast, no recommendation. This page describes Pfizer Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.